Patent · US Active

Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions

US9701967B2 · kind B2 · utility

3Cited by
32References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2016
Grant dateJul 11, 2017
Priority date
Expiry dateJun 22, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aptamers that bind PDGF and aptamers that bind VEGF are provided. In addition, aptamer constructs comprising a PDGF aptamer and a VEGF aptamer are provided. Pharmaceutical compositions comprising the aptamers and aptamer constructs are provided, as well as methods of treating conditions using the aptamers and aptamer constructs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.